James Doubek
James Doubek is an associate editor and reporter for NPR. He frequently covers breaking news for NPR.org and NPR's hourly newscast. In 2018, he reported feature stories for NPR's business desk on topics including electric scooters, cryptocurrency, and small business owners who lost out when Amazon made a deal with Apple.
In the fall of that year, Doubek was selected for NPR's internal enrichment rotation to work as an audio producer for Weekend Edition. He spent two months pitching, producing, and editing interviews and pieces for broadcast.
As an associate producer for NPR's digital content team, Doubek edits online stories and manages NPR's website and social media presence.
He got his start at NPR as an intern at the Washington Desk, where he made frequent trips to the Supreme Court and reported on political campaigns.
-
Among the states hardest-hit by a new wave of coronavirus cases linked to the highly contagious delta variant, Arkansas has "startling numbers" of new COVID-19 cases, Gov. Asa Hutchison says. -
"To defend this Nation, we need a healthy and ready force," Defense Secretary Lloyd Austin said in a memo to employees. Already, about 62% of active-duty service members are fully vaccinated.
-
Documentary filmmaker Alex Gibney investigated the opioid crisis. He says it was created by pharmaceutical companies, distributors, pharmacists and doctors, all looking to profit.
-
Unless people are packed together, "there really just is not much spread happening outdoors," Dr. Ashish Jha of Brown University's School of Public Health says.
-
Dr. Katherine O'Brien of the World Health Organization says poor countries are able to get their populations vaccinated — they just need the doses.
-
On New Year's Eve, 25-year-old Tommy Raskin killed himself. Rep. Jamie Raskin of Maryland talked with NPR about his son's life and the outpouring of tributes to him.
-
Ernest Grant, the president of the American Nurses Association, says historical abuses have left Black people with a distrust of vaccines. Now he's part of a coronavirus vaccine trial.
-
But Dr. Francis Collins says it's unlikely a vaccine will be approved before late November. He also urges people to trust health experts like Anthony Fauci who "don't really have an ax to grind."
-
Vaccine maker Novavax is starting a large coronavirus vaccine trial in the U.K. Gregory Glenn, the company's president of research and development, talks with NPR about how vaccines are tested.
-
Dr. Ali Khan, a former CDC official, says "it's becoming harder to trust what CDC tells us" after the agency posted, then deleted, information on coronavirus transmission. It's the latest flip-flop.
